significantly decreased glenohumeral superior translation and decreased maximum deltoid cumulative forces ( 54 ). InSpace biodegradable implantable balloon (subacromial spacer) In 2021, the US Food and Drug Administration approved the use of a
significantly decreased glenohumeral superior translation and decreased maximum deltoid cumulative forces ( 54 ). InSpace biodegradable implantable balloon (subacromial spacer) In 2021, the US Food and Drug Administration approved the use of a
Online ISSN: 2058-5241
Print ISSN: 2396-7544
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519